ANAPTYSBIO, INC Quarterly Nonoperating Income (Expense) in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Anaptysbio, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2016 to Q3 2024.
  • Anaptysbio, Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$10.1M, a 2481% decline year-over-year.
  • Anaptysbio, Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$18.2M, a 4135% decline year-over-year.
  • Anaptysbio, Inc annual Nonoperating Income (Expense) for 2023 was $788K.
  • Anaptysbio, Inc annual Nonoperating Income (Expense) for 2022 was -$13.5M, a 1279% decline from 2021.
  • Anaptysbio, Inc annual Nonoperating Income (Expense) for 2021 was -$982K, a 125% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$18.2M -$10.1M -$10.5M -2481% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$7.72M -$6.33M -$6.63M -2224% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$1.09M -$1.74M -$1.88M -1288% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $788K -$80K +$336K +80.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $452K $424K +$4.29M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$3.84M $298K +$5.05M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$8.89M $146K +$4.65M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$13.5M -$416K +$965K +69.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$14.5M -$3.87M -$3.97M -4089% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$10.5M -$4.76M -$4.86M -4672% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$5.69M -$4.51M -$4.7M -2376% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$982K -$1.38M -$1.68M -559% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 $700K $97K -$472K -83% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.17M $104K -$983K -90.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $2.16M $198K -$1.79M -90.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $3.95M $301K -$1.67M -84.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $5.62M $569K -$2.09M -78.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $7.71M $1.09M -$1.55M -58.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $9.26M $1.99M -$684K -25.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $9.94M $1.97M -$504K -20.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-07
Q3 2019 $10.4M $2.66M +$1.73M +186% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $8.72M $2.64M +$1.84M +231% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $6.88M $2.68M +$2M +299% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $4.87M $2.48M +$2.19M +754% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $2.69M $929K +$932K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $1.76M $797K +$926K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $829K $671K +$2.12M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$1.29M $290K +$1.69M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$2.98M -$3K +$37K +92.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$3.02M -$129K -$88K -215% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$2.93M -$1.45M -$1.7M -676% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$1.23M -$1.4M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$40K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$41K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $251K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.